Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 10/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 10/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 7/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3681397 | 1.00 | CHRNB2 (0.40) | CHRNB2CHRNA4CHRNB4CHRNA3SPHK1 | |
| SCHEMBL15199431 | 0.83 | LMNA (0.43) | SPHK1LMNA | |
| SCHEMBL10498087 | 0.82 | LMNA (0.48) | SPHK1LMNA | |
| SCHEMBL1925735 | 0.82 | LMNA (0.48) | SPHK1LMNA | |
| SCHEMBL28371503 | 0.82 | LMNA (0.48) | SPHK1LMNA | |
| SCHEMBL23666631 | 0.82 | LMNA (0.48) | SPHK1LMNA | |
| SCHEMBL3715852 | 0.82 | LMNA (0.48) | SPHK1LMNA | |
| SCHEMBL7763388 | 0.82 | CHRNB2 (0.52) | CHRNB2CHRNA4CHRNB4CHRNA3 | |
| SCHEMBL398667 | 0.82 | LMNA (0.48) | SPHK1LMNA | |
| SCHEMBL8011379 | 0.82 | LMNA (0.48) | SPHK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10736325-B2 | Surfactants and formulations | MONSANTO TECHNOLOGY LLC (US) | 2020-08-11 | — | — | US | disclosed |
| US-20100234228-A1 | NOVEL SURFACTANTS AND FORMULATIONS | MONSANTO TECHNOLOGY LLC (US) | 2010-09-16 | — | — | US | disclosed |
| US-7049270-B2 | Potassium glyphosate formulations | MONSANTO TECHNOLOGY LLC (US) | 2006-05-23 | — | — | US | disclosed |
| US-20050261130-A1 | Novel surfactants and formulations | MONSANTO TECHNOLOGY LLC (US) | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261130-A1 | Novel surfactants and formulations | PHOSPHO1, GNMT, DDT | CHRNB2 2169/4885CHRNA4 2080/4885CHRNB4 1775/4885 |
| US-20100234228-A1 | NOVEL SURFACTANTS AND FORMULATIONS | PHOSPHO1, GNMT, DDT | CHRNB2 2169/4885CHRNA4 2080/4885CHRNB4 1775/4885 |
| US-10736325-B2 | Surfactants and formulations | PHOSPHO1, GNMT, DDT | CHRNB2 2054/4885CHRNA4 1790/4885CHRNB4 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.